Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v4-EN
Language English English
Date Updated 2024-02-27 2024-02-26
Drug Identification Number 02494574 02494574
Brand name CLADRIBINE INJECTION CLADRIBINE INJECTION
Common or Proper name CLADRIBINE INJECTION CLADRIBINE INJECTION
Company Name GENERIC MEDICAL PARTNERS INC GENERIC MEDICAL PARTNERS INC
Ingredients CLADRIBINE CLADRIBINE
Strength(s) 1MG 1MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1mg/ml 10ml Vial 1mg/ml 10ml Vial
ATC code L01BB L01BB
ATC description ANTIMETABOLITES ANTIMETABOLITES
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2024-01-25 2024-01-25
Actual start date 2024-01-25 2024-01-25
Estimated end date 2024-02-15 2024-02-15
Actual end date 2024-02-26 2024-02-26
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Cladribine Injection 1mg/ml 10 ml vial UPC 870573001434 is now available. It is not on allocation. Normal demand levels can be supplied. Cladribine Injection 1mg/ml 10 ml vial UPC 870573001434 is now available. It is not on allocation. Normal demand levels can be supplied.
Health Canada comments